Hypertension drug may hold promise for Alzheimer's disease

June 17th, 2019 | Posted by admin in Uncategorized

The blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center, without affecting other brain regions among people with Alzheimer's disease. These findings indicate that the known decrease in cerebral blood flow in patients with Alzheimer's can be reversed in some regions. However, it is unclear if this translates to clinical benefits.
Source: Medicine Science Daily

You can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.

Leave a Reply

Your email address will not be published.